Selected research
Market Analysis & Forecast
Global Medicinal Carbon Market Analysis and Forecast 2026-2032
Market perspective
The global Medicinal Carbon market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Medicinal Carbon's global sales reached XX (t) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned NORIT as the global sales leader, a title it has maintained for several consecutive years. Notably, NORIT's performance in primary markets is also remarkable. In the Chinese market, sales were XX (t), a change of XX% from the previous year. In Europe, sales were XX (t), showing a year-on-year of XX%. In the US, sales were XX (t), a year-on-year change of XX%.
The major global manufacturers in the Medicinal Carbon market include NORIT, Dupont, Witco Chemical Corporation, Osaka Gas Co.,Ltd., Kuraray, Ingevity, Haycarb PLC, Emis Vito and EcoFriend Carbon, etc. In 2025, the top three vendors accounted for approximately % of the revenue.
Read the full market overview
In terms of production side, this report researches the Medicinal Carbon production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.
In terms of consumption side, this report focuses on the sales of Medicinal Carbon by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.
This report presents an overview of global market for Medicinal Carbon, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Medicinal Carbon, also provides the consumption of main regions and countries. Of the upcoming market potential for Medicinal Carbon, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Medicinal Carbon sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medicinal Carbon market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Medicinal Carbon sales, projected growth trends, production technology, application and end-user industry.
Medicinal Carbon Segment by Company
NORIT
Dupont
Witco Chemical Corporation
Osaka Gas Co.,Ltd.
Kuraray
Ingevity
Haycarb PLC
Emis Vito
EcoFriend Carbon
Dolder
Calgon Carbon Corporation
Barnebey Cheney
Atlas Carbon
Medicinal Carbon Segment by Type
Chemical Activation
Physical Activation
Medicinal Carbon Segment by Application
Ostomy
Decolourisation of Pharmaceuticals
Dialysis/Blood Cleaning
Wound Odour Removal
Emergency Poison Antidote
Medicinal Carbon Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medicinal Carbon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medicinal Carbon and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medicinal Carbon.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Medicinal Carbon production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of Medicinal Carbon in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of Medicinal Carbon manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medicinal Carbon sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chemical Activation
- Physical Activation
Applications
- Ostomy
- Decolourisation of Pharmaceuticals
- Dialysis/Blood Cleaning
- Wound Odour Removal
- Emergency Poison Antidote
Companies covered
- NORIT
- Dupont
- Witco Chemical Corporation
- Osaka Gas Co.,Ltd.
- Kuraray
- Ingevity
- Haycarb PLC
- Emis Vito
- EcoFriend Carbon
- Dolder
- Calgon Carbon Corporation
- Barnebey Cheney
- Atlas Carbon
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Medicinal Carbon Market by Type
- 1.2.1 Global Medicinal Carbon Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Chemical Activation
- 1.2.3 Physical Activation
- 1.3 Medicinal Carbon Market by Application
- 1.3.1 Global Medicinal Carbon Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Ostomy
- 1.3.3 Decolourisation of Pharmaceuticals
- 1.3.4 Dialysis/Blood Cleaning
- 1.3.5 Wound Odour Removal
- 1.3.6 Emergency Poison Antidote
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Medicinal Carbon Market Dynamics
- 2.1 Medicinal Carbon Industry Trends
- 2.2 Medicinal Carbon Industry Drivers
- 2.3 Medicinal Carbon Industry Opportunities and Challenges
- 2.4 Medicinal Carbon Industry Restraints
3 Global Medicinal Carbon Production Overview
- 3.1 Global Medicinal Carbon Production Capacity (2021-2032)
- 3.2 Global Medicinal Carbon Production by Region: 2021 VS 2025 VS 2032
- 3.3 Global Medicinal Carbon Production by Region
- 3.3.1 Global Medicinal Carbon Production by Region (2021-2026)
- 3.3.2 Global Medicinal Carbon Production by Region (2027-2032)
- 3.3.3 Global Medicinal Carbon Production Market Share by Region (2021-2032)
- 3.4 North America
- 3.5 Europe
- 3.6 China
- 3.7 Japan
4 Global Market Growth Prospects
- 4.1 Global Medicinal Carbon Revenue Estimates and Forecasts (2021-2032)
- 4.2 Global Medicinal Carbon Revenue by Region
- 4.2.1 Global Medicinal Carbon Revenue by Region: 2021 VS 2025 VS 2032
- 4.2.2 Global Medicinal Carbon Revenue by Region (2021-2026)
- 4.2.3 Global Medicinal Carbon Revenue by Region (2027-2032)
- 4.2.4 Global Medicinal Carbon Revenue Market Share by Region (2021-2032)
- 4.3 Global Medicinal Carbon Sales Estimates and Forecasts 2021-2032
- 4.4 Global Medicinal Carbon Sales by Region
- 4.4.1 Global Medicinal Carbon Sales by Region: 2021 VS 2025 VS 2032
- 4.4.2 Global Medicinal Carbon Sales by Region (2021-2026)
- 4.4.3 Global Medicinal Carbon Sales by Region (2027-2032)
- 4.4.4 Global Medicinal Carbon Sales Market Share by Region (2021-2032)
- 4.5 North America
- 4.6 Europe
- 4.7 China
- 4.8 Asia (Excluding China)
- 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
- 5.1 Global Medicinal Carbon Revenue by Manufacturers
- 5.1.1 Global Medicinal Carbon Revenue by Manufacturers (2021-2026)
- 5.1.2 Global Medicinal Carbon Revenue Market Share by Manufacturers (2021-2026)
- 5.1.3 Global Medicinal Carbon Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 5.2 Global Medicinal Carbon Sales by Manufacturers
- 5.2.1 Global Medicinal Carbon Sales by Manufacturers (2021-2026)
- 5.2.2 Global Medicinal Carbon Sales Market Share by Manufacturers (2021-2026)
- 5.2.3 Global Medicinal Carbon Manufacturers Sales Share Top 10 and Top 5 in 2025
- 5.3 Global Medicinal Carbon Sales Price by Manufacturers (2021-2026)
- 5.4 Global Medicinal Carbon Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 5.5 Global Medicinal Carbon Key Manufacturers Manufacturing Sites & Headquarters
- 5.6 Global Medicinal Carbon Manufacturers, Product Type & Application
- 5.7 Global Medicinal Carbon Manufacturers Commercialization Time
- 5.8 Market Competitive Analysis
- 5.8.1 Global Medicinal Carbon Market CR5 and HHI
- 5.8.2 2025 Medicinal Carbon Tier 1, Tier 2, and Tier 3
6 Medicinal Carbon Market by Type
- 6.1 Global Medicinal Carbon Revenue by Type
- 6.1.1 Global Medicinal Carbon Revenue by Type (2021-2032) & (US$ Million)
- 6.1.2 Global Medicinal Carbon Revenue Market Share by Type (2021-2032)
- 6.2 Global Medicinal Carbon Sales by Type
- 6.2.1 Global Medicinal Carbon Sales by Type (2021-2032) & (t)
- 6.2.2 Global Medicinal Carbon Sales Market Share by Type (2021-2032)
- 6.3 Global Medicinal Carbon Price by Type
7 Medicinal Carbon Market by Application
- 7.1 Global Medicinal Carbon Revenue by Application
- 7.1.1 Global Medicinal Carbon Revenue by Application (2021-2032) & (US$ Million)
- 7.1.2 Global Medicinal Carbon Revenue Market Share by Application (2021-2032)
- 7.2 Global Medicinal Carbon Sales by Application
- 7.2.1 Global Medicinal Carbon Sales by Application (2021-2032) & (t)
- 7.2.2 Global Medicinal Carbon Sales Market Share by Application (2021-2032)
- 7.3 Global Medicinal Carbon Price by Application
8 Company Profiles
- 8.1 NORIT
- 8.1.1 NORIT Company Information
- 8.1.2 NORIT Business Overview
- 8.1.3 NORIT Medicinal Carbon Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.1.4 NORIT Medicinal Carbon Product Portfolio
- 8.1.5 NORIT Recent Developments
- 8.2 Dupont
- 8.2.1 Dupont Company Information
- 8.2.2 Dupont Business Overview
- 8.2.3 Dupont Medicinal Carbon Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.2.4 Dupont Medicinal Carbon Product Portfolio
- 8.2.5 Dupont Recent Developments
- 8.3 Witco Chemical Corporation
- 8.3.1 Witco Chemical Corporation Company Information
- 8.3.2 Witco Chemical Corporation Business Overview
- 8.3.3 Witco Chemical Corporation Medicinal Carbon Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.3.4 Witco Chemical Corporation Medicinal Carbon Product Portfolio
- 8.3.5 Witco Chemical Corporation Recent Developments
- 8.4 Osaka Gas Co.,Ltd.
- 8.4.1 Osaka Gas Co.,Ltd. Company Information
- 8.4.2 Osaka Gas Co.,Ltd. Business Overview
- 8.4.3 Osaka Gas Co.,Ltd. Medicinal Carbon Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.4.4 Osaka Gas Co.,Ltd. Medicinal Carbon Product Portfolio
- 8.4.5 Osaka Gas Co.,Ltd. Recent Developments
- 8.5 Kuraray
- 8.5.1 Kuraray Company Information
- 8.5.2 Kuraray Business Overview
- 8.5.3 Kuraray Medicinal Carbon Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.5.4 Kuraray Medicinal Carbon Product Portfolio
- 8.5.5 Kuraray Recent Developments
- 8.6 Ingevity
- 8.6.1 Ingevity Company Information
- 8.6.2 Ingevity Business Overview
- 8.6.3 Ingevity Medicinal Carbon Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.6.4 Ingevity Medicinal Carbon Product Portfolio
- 8.6.5 Ingevity Recent Developments
- 8.7 Haycarb PLC
- 8.7.1 Haycarb PLC Company Information
- 8.7.2 Haycarb PLC Business Overview
- 8.7.3 Haycarb PLC Medicinal Carbon Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.7.4 Haycarb PLC Medicinal Carbon Product Portfolio
- 8.7.5 Haycarb PLC Recent Developments
- 8.8 Emis Vito
- 8.8.1 Emis Vito Company Information
- 8.8.2 Emis Vito Business Overview
- 8.8.3 Emis Vito Medicinal Carbon Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.8.4 Emis Vito Medicinal Carbon Product Portfolio
- 8.8.5 Emis Vito Recent Developments
- 8.9 EcoFriend Carbon
- 8.9.1 EcoFriend Carbon Company Information
- 8.9.2 EcoFriend Carbon Business Overview
- 8.9.3 EcoFriend Carbon Medicinal Carbon Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.9.4 EcoFriend Carbon Medicinal Carbon Product Portfolio
- 8.9.5 EcoFriend Carbon Recent Developments
- 8.10 Dolder
- 8.10.1 Dolder Company Information
- 8.10.2 Dolder Business Overview
- 8.10.3 Dolder Medicinal Carbon Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.10.4 Dolder Medicinal Carbon Product Portfolio
- 8.10.5 Dolder Recent Developments
- 8.11 Calgon Carbon Corporation
- 8.11.1 Calgon Carbon Corporation Company Information
- 8.11.2 Calgon Carbon Corporation Business Overview
- 8.11.3 Calgon Carbon Corporation Medicinal Carbon Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.11.4 Calgon Carbon Corporation Medicinal Carbon Product Portfolio
- 8.11.5 Calgon Carbon Corporation Recent Developments
- 8.12 Barnebey Cheney
- 8.12.1 Barnebey Cheney Company Information
- 8.12.2 Barnebey Cheney Business Overview
- 8.12.3 Barnebey Cheney Medicinal Carbon Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.12.4 Barnebey Cheney Medicinal Carbon Product Portfolio
- 8.12.5 Barnebey Cheney Recent Developments
- 8.13 Atlas Carbon
- 8.13.1 Atlas Carbon Company Information
- 8.13.2 Atlas Carbon Business Overview
- 8.13.3 Atlas Carbon Medicinal Carbon Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.13.4 Atlas Carbon Medicinal Carbon Product Portfolio
- 8.13.5 Atlas Carbon Recent Developments
9 North America
- 9.1 North America Medicinal Carbon Market Size by Type
- 9.1.1 North America Medicinal Carbon Revenue by Type (2021-2032)
- 9.1.2 North America Medicinal Carbon Sales by Type (2021-2032)
- 9.1.3 North America Medicinal Carbon Price by Type (2021-2032)
- 9.2 North America Medicinal Carbon Market Size by Application
- 9.2.1 North America Medicinal Carbon Revenue by Application (2021-2032)
- 9.2.2 North America Medicinal Carbon Sales by Application (2021-2032)
- 9.2.3 North America Medicinal Carbon Price by Application (2021-2032)
- 9.3 North America Medicinal Carbon Market Size by Country
- 9.3.1 North America Medicinal Carbon Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 North America Medicinal Carbon Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 North America Medicinal Carbon Price by Country (2021-2032)
- 9.3.4 United States
- 9.3.5 Canada
- 9.3.6 Mexico
10 Europe
- 10.1 Europe Medicinal Carbon Market Size by Type
- 10.1.1 Europe Medicinal Carbon Revenue by Type (2021-2032)
- 10.1.2 Europe Medicinal Carbon Sales by Type (2021-2032)
- 10.1.3 Europe Medicinal Carbon Price by Type (2021-2032)
- 10.2 Europe Medicinal Carbon Market Size by Application
- 10.2.1 Europe Medicinal Carbon Revenue by Application (2021-2032)
- 10.2.2 Europe Medicinal Carbon Sales by Application (2021-2032)
- 10.2.3 Europe Medicinal Carbon Price by Application (2021-2032)
- 10.3 Europe Medicinal Carbon Market Size by Country
- 10.3.1 Europe Medicinal Carbon Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 10.3.2 Europe Medicinal Carbon Sales by Country (2021 VS 2025 VS 2032)
- 10.3.3 Europe Medicinal Carbon Price by Country (2021-2032)
- 10.3.4 Germany
- 10.3.5 France
- 10.3.6 U.K.
- 10.3.7 Italy
- 10.3.8 Russia
- 10.3.9 Spain
- 10.3.10 Netherlands
- 10.3.11 Switzerland
- 10.3.12 Sweden
11 China
- 11.1 China Medicinal Carbon Market Size by Type
- 11.1.1 China Medicinal Carbon Revenue by Type (2021-2032)
- 11.1.2 China Medicinal Carbon Sales by Type (2021-2032)
- 11.1.3 China Medicinal Carbon Price by Type (2021-2032)
- 11.2 China Medicinal Carbon Market Size by Application
- 11.2.1 China Medicinal Carbon Revenue by Application (2021-2032)
- 11.2.2 China Medicinal Carbon Sales by Application (2021-2032)
- 11.2.3 China Medicinal Carbon Price by Application (2021-2032)
12 Asia (Excluding China)
- 12.1 Asia Medicinal Carbon Market Size by Type
- 12.1.1 Asia Medicinal Carbon Revenue by Type (2021-2032)
- 12.1.2 Asia Medicinal Carbon Sales by Type (2021-2032)
- 12.1.3 Asia Medicinal Carbon Price by Type (2021-2032)
- 12.2 Asia Medicinal Carbon Market Size by Application
- 12.2.1 Asia Medicinal Carbon Revenue by Application (2021-2032)
- 12.2.2 Asia Medicinal Carbon Sales by Application (2021-2032)
- 12.2.3 Asia Medicinal Carbon Price by Application (2021-2032)
- 12.3 Asia Medicinal Carbon Market Size by Country
- 12.3.1 Asia Medicinal Carbon Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 Asia Medicinal Carbon Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 Asia Medicinal Carbon Price by Country (2021-2032)
- 12.3.4 Japan
- 12.3.5 South Korea
- 12.3.6 India
- 12.3.7 Australia
- 12.3.8 Taiwan
- 12.3.9 Southeast Asia
13 South America, Middle East and Africa
- 13.1 SAMEA Medicinal Carbon Market Size by Type
- 13.1.1 SAMEA Medicinal Carbon Revenue by Type (2021-2032)
- 13.1.2 SAMEA Medicinal Carbon Sales by Type (2021-2032)
- 13.1.3 SAMEA Medicinal Carbon Price by Type (2021-2032)
- 13.2 SAMEA Medicinal Carbon Market Size by Application
- 13.2.1 SAMEA Medicinal Carbon Revenue by Application (2021-2032)
- 13.2.2 SAMEA Medicinal Carbon Sales by Application (2021-2032)
- 13.2.3 SAMEA Medicinal Carbon Price by Application (2021-2032)
- 13.3 SAMEA Medicinal Carbon Market Size by Country
- 13.3.1 SAMEA Medicinal Carbon Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 13.3.2 SAMEA Medicinal Carbon Sales by Country (2021 VS 2025 VS 2032)
- 13.3.3 SAMEA Medicinal Carbon Price by Country (2021-2032)
- 13.3.4 Brazil
- 13.3.5 Argentina
- 13.3.6 Chile
- 13.3.7 Colombia
- 13.3.8 Peru
- 13.3.9 Saudi Arabia
- 13.3.10 Israel
- 13.3.11 UAE
- 13.3.12 Turkey
- 13.3.13 Iran
- 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
- 14.1 Medicinal Carbon Value Chain Analysis
- 14.1.1 Medicinal Carbon Key Raw Materials
- 14.1.2 Raw Materials Key Suppliers
- 14.1.3 Manufacturing Cost Structure
- 14.1.4 Medicinal Carbon Production Mode & Process
- 14.2 Medicinal Carbon Sales Channels Analysis
- 14.2.1 Direct Comparison with Distribution Share
- 14.2.2 Medicinal Carbon Distributors
- 14.2.3 Medicinal Carbon Customers
15 Concluding Insights
16 Appendix
- 16.1 Reasons for Doing This Study
- 16.2 Research Methodology
- 16.3 Research Process
- 16.4 Authors List of This Report
- 16.5 Data Source
- 16.5.1 Secondary Sources
- 16.5.2 Primary Sources
- 16.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst